CSI Market
Sign In | Register

Kraig Biocraft Laboratories Inc (KBLB) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access KBLB Annual Cash Flow →
A period-by-period view of cash flow from Kraig Biocraft Laboratories Inc to Jun 30 2025 helps clarify how Jun 30 2026's cash position has changed over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-1.85
Depreciation & amortization0.01
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Asset Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.14
R & D, Environmental and Other Expense0.00
Gain (Loss) on Sale of Assets and Asset Impairment Charges0.00
Share-based Compensation0.06
Income (Loss) from Equity Method Investments0.00
Paid-in-Kind Interest0.04
Common Stock Issuable For Compensation-
Change In Fair Value Derivative Liability-
Warrant Based Compensation-
Stock Issued During Period Shares Stock Options Exercised-
Write Off Of Note Receivable-
Shares Issued In Connection With Cashless Warrants Exercise-
Forgiveness Of Accrued Payroll Related Party-
Bad Debt Expense-
Debt Instrument Decrease Forgiveness-
Right Of Use Asset Obtained In Exchange For Operating Lease Liability-
Imputed Interest Related Party-
Impairment Of Right Of Use Asset-
Warrants Issue Cancelled To Consultants0.21
Net Change In Unrealized Gain Loss On Investment In Gold Bullion-0.02
Increase Decrease In Operating Lease Liability-0.01
Income taxes0.00
Losses/ -gains on Investments net0.05
Increase (Decrease) in Accounts Receivable0.00
Accounts Payable0.44
Increase (Decrease) in Interest Payable, Net0.00
Increase (Decrease) in Security Deposits0.00
Increase (Decrease) in Prepaid Expense0.00
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-0.01
Discontinued operations0.00
Net Cash flow from Operating Activities-1.13
Investing Activities
Capital Expenditures-0.04
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Held-to-maturity Securities0.00
Payments to Acquire Held-to-maturity Securities0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Proceeds from Sale and Maturity of Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-0.04
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net2.77
Proceeds From S B A Paycheck Protection Loan-
Contributed Capital Related Parties-
Proceeds From Sba Paycheck Protection Loan-
Proceeds From Standby Equity Purchase Agreement1.64
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities2.77
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-1.17
Total Cash Flow1.60
4 historic quarters locked

Sign in to unlock the full Kraig Biocraft Laboratories Inc cash flow history.

Sign In Create Free Account

About Kraig Biocraft Laboratories Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 13, 2026
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001493152-26-037818

Figures are derived from filed reports and may be restated. Historical data is subject to revision.